Yannis Metaxas - Kantonsspital Munsterlingen

M. Joerger, P. Knüsel, E. Alejandre-Lafont,Y. Metaxas,M.T. Mark,R.A.F. von Moos,K. Gysel,K. Eckhardt, J. Glaus Garzon,K-L. Koster, Y. Wittwer,S. Tissot,L. Flatz, L. Alleruzzo, S.K. Lam, D. Anderson, W. Chen, E. Baskin-Bey, T. Hode

Immuno-oncology technology (2022): 100306-100306

Cited0Views0Bibtex

1495P SAKK 57/16 Nab-Paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): Final Results from the Phase Ib/II Trial with >2y Median Follow Up

A. Digklia,A. Kollar, M-N. Kronig,Christian Britschgi,T. Rordorf,M. Joerger,F. Krasniqi,Y. Metaxas,I. Colombo,D. Dietrich,S. Chiquet,K. Ribi,C.A. Rothermundt

Annals of Oncology (2022): S1230-S1230

Cited1Views0Bibtex

19P Effects of CTLA-4 single nucleotide polymorphisms (SNPs) on toxicity of ipilimumab-containing regimens in patients with advanced stage melanoma

K.D. Joode,A. Rojas Mora,R. Van Schaik,A. Zippelius,A.A.M. Van der Veldt,C.L. Gerard,H. Läubli,O.A. Michielin,R.A.F. von Moos,M. Joerger,M.P. Levesque,S. Aeppli,J. Mangana,C. Mangas,S. Meyer,S. Leoni-Parvex,R.H. Mathijssen,Y. Metaxas

Immuno-Oncology and Technologyno. 5 (2022): 100124-194

Cited0Views0WOSBibtex

A Phase I Trial of Lurbinectedin in Combination with Cisplatin in Patients with Advanced Solid Tumors

Metaxas Yannis,Kahatt Carmen,Alfaro Vicente,Fudio Salvador,Zeaiter Ali,Plummer Ruth,Sessa Cristiana,Von Moos Roger,Forster Martin,Stathis Anastasios

Investigational new drugs（2021）

Cited1Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn